Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198577 | SCV001369567 | uncertain significance | NPHP3-related Meckel-like syndrome | 2019-08-12 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Prevention |
RCV004545119 | SCV004781364 | likely pathogenic | NPHP3-related disorder | 2023-10-27 | no assertion criteria provided | clinical testing | The NPHP3 c.1275+3A>T variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature. It has been observed in the compound heterozygous state with a NPHP3 truncating pathogenic variant in an individual with NPHP3-related disease (Internal Data, PreventionGenetics). RNA sequencing targeted variant analysis indicates this variant impacts splicing (Internal Data, PreventionGenetics). This variant is reported in 3 of ~251,000 alleles in gnomAD (http://gnomad.broadinstitute.org/variant/3-132426942-T-A). This variant is interpreted as likely pathogenic. |